New Low-Cost Drug to Help You Quit Smoking
Low-cost treatment triples chances of quitting smoking.
Smoking is the most preventable cause of death in the United States and many other parts of the world. Smoking not only causes respiratory problems and lung cancer, it greatly increases risk for cardiovascular disease, stroke and heart attack — all of which can result in death. But even for those who decide to quit, maintaining abstinence from smoking can be a challenge, even with the help of smoking cessation aids. That’s why researchers continue to work to identify effective smoking cessation tools such as drugs, patches and even gum that help smokers quit the habit —permanently.
Fortunately, a recent study helped to identify a dsx, which is not only effective and safe in helping patients quit smoking, it is a low-cost treatment that won’t break the bank. This study published in the New England Journal of Medicine assessed the use of cytisine as a smoking cessation aid among 740 adult smokers — all of whom wanted to quit. Upon quitting, all participants received a minimal amount of counseling over the course of 25 days, while only half received cytisine during this time. After follow-up, researchers found that adults taking cytisine during treatment were more than 3 times more likely to remain non-smokers for 12 months after their initial quitting period.
Findings from this study are very encouraging for smoking cessation both within the United States and worldwide. Although many drugs and tools have been proven effective in helping people quit smoking, not all help people kick the habit permanently, and many are expensive. However, cytisine may just be as effective as other smoking cessation treatments while costing significantly less. The hope is that with more research, cytisine will offer an affordable smoking cessation option for adults worldwide, helping to reduce risk for cancers and heart disease, and improving the health of current smokers.
Questions for You to Consider